Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

Hepatology

Volumn 53, Issue 3, 2011, Pages 935-944

  Gómez Hurtado, Isabel ^a   Zapater, Pedro ^a,b   Bellot, Pablo ^a,b   Pascual, Sonia ^a,b   Pérez Mateo, Miguel ^a   Such, José ^a,b   Francés, Rubén ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CYCLOOXYGENASE 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; NORFLOXACIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BLOOD SAMPLING; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDIATOR; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; STIMULATION; STREPTOCOCCUS PNEUMONIAE; UPREGULATION;

AGED; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DNA, BACTERIAL; DOWN-REGULATION; FEMALE; HEME OXYGENASE-1; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NORFLOXACIN; PERITONITIS; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 79952215741     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24102     Document Type: Article

References (33)

1. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992; 23: 217-244.
2. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669-674.
3. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17: 203-217.
4. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-1272.
5. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo- controlled trial. HEPATOLOGY 1990; 12: 716-724.
6. Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133: 818-824.
7. Frances R, Zapater P, Gonzalez-Navajas JM, Munoz C, Cano R, Moreu R, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. HEPATOLOGY 2008; 47: 978-985.
8. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. HEPATOLOGY 1993; 18: 1139-1143.
9. Zapater P, Frances R, Gonzalez-Navajas JM, de la Hoz MA, Moreu R, Pascual S, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. HEPATOLOGY 2008; 48: 1924-1931.
10. Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C, et al. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 2009; 137: 1669-1679.
11. Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990; 28: 2811-2812.
12. Frances R, Benlloch S, Zapater P, Gonzalez JM, Lozano B, Munoz C, et al. A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. HEPATOLOGY 2004; 39: 484-491.
13. Gonzalez-Navajas JM, Bellot P, Frances R, Zapater P, Munoz C, Garci A-P, et al. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol 2008; 48: 61-67.
14. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993; 73: 1121-1127.
15. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8: 240-246.
16. Drechsler Y, Dolganiuc A, Norkina O, Romics L, Li W, Kodys K, et al. Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 2006; 177: 2592-2600.
17. Hunter MM, Wang A, Hirota CL, McKay DM. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 2005; 174: 7368-7375.
18. Goodier MR, Londei M. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. J Immunol 2000; 165: 139-147.
19. van der PT, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995; 155: 5397-5401.
20. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. HEPATOLOGY 1995; 22: 1436-1439.
21. Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2002; 26: 74-82.
22. - production in a two-hit model of alcohol intoxication and burn injury. J Immunol 2008; 180: 6933-6940.
23. Mandal P, Park PH, McMullen MR, Pratt BT, Nagy LE. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. HEPATOLOGY 2010; 51: 1420-1429.
24. Liu LG, Yan H, Zhang W, Yao P, Zhang XP, Sun XF, et al. Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed Environ Sci 2004; 17: 315-326.
25. Ejima K, Layne MD, Carvajal IM, Kritek PA, Baron RM, Chen YH, et al. Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J 2003; 17: 1325-1327.
26. Ejima K, Perrella MA. Alteration in heme oxygenase-1 and nitric oxide synthase-2 gene expression during endotoxemia in cyclooxygenase-2-deficient mice. Antioxid Redox Signal 2004; 6: 850-857.
27. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177: 1205-1208.
28. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547-550.
29. Santucci L, Fiorucci S, Chiorean M, Brunori PM, Di Matteo FM, Sidoni A, et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 1996; 111: 736-744.
30. Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis 2003; 3: 359-371.
31. Tabary O, Muselet C, Escotte S, Antonicelli F, Hubert D, Dusser D, et al. Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the I(k)B kinase alpha/beta complex. Am J Pathol 2003; 162: 293-302.
32. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. HEPATOLOGY 2003; 37: 208-217.
33. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180: 5771-5777.